Journal of Medicinal Chemistry · 2004 · 106 citations · 11 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryDrug MetabolismStructure-activity RelationshipsCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug-metabolizing EnzymesEnzyme InhibitionAntiproliferative AgentsAntiproliferative Drug ActionChemical Enzyme InhibitorsCytochrome P450 Enzyme InhibitionInhibitor ClassificationSelectivity
A dozen 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3) were prepared, differing not only at the stereogenic sulfoximine stereocenter but also at the A-ring. Although these sulfoximines were not active transcriptionally and were only very weakly antiproliferative, some of them are powerful hydroxylase enzyme inhibitors. Specifically, 24-(S)-NH phenyl sulfoximine 3a is an extremely potent CYP24 inhibitor (IC(50) = 7.4 nM) having low calcemic activity. In addition, this compound shows high selectivity toward the CYP24 enzyme in comparison to CYP27A1 (IC(50) > 1000 nM) and CYP27B (IC(50) = 554 nM).
11
Carl R. Johnson, Eugene R. Janiga · Journal of the American Chemical Society · 1973 · 87 citations
Gary H. Posner, Jae Kyoo Lee, M. Christina White et al. · The Journal of Organic Chemistry · 1997 · 81 citations